Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Sartorius AG    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sartorius : to open new Customer Interaction Center in North America

11/17/2020 | 10:19am EST
DateOct 29, 20
Sartorius AG
Press Release
Sartorius to open new Customer Interaction Center in North America

Marlborough, October 29, 2020

  • 40,000-square-foot Customer Interaction Center in Marlborough, Massachusetts
  • 100 new jobs created from initiative
  • Opening of first units early 2021

Construction at the new site in Marlborough, Massachusetts.

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, is expanding its presence in Massachusetts with a North American Customer Interaction Center. Sartorius will be opening first units of the new 40,000-square-foot Customer Interaction Center in Marlborough in early 2021. 'With our new site in Marlborough, we will be optimizing factory acceptance testing and commissioning of new bioprocess equipment supplied to the North American market. This investment will translate into tangible benefits for our customers, employees, suppliers, and the local community,' said the President of Sartorius North America, Mary Lavin.

The new site will be a focal point for customers in what is now one of the world's largest development hubs for biopharmaceutical products and will create around 100 new jobs. These jobs will be in the engineering disciplines of process and mechanical design as well as in electrical and automation engineering. Additionally, Sartorius will be employing production technicians, customer service and support staff. This is the first time Sartorius will be designing, building and delivering industry-leading manufacturing solutions in North America for its North American customers.

The Customer Interaction Center initiative will enable Sartorius to scale up its operations and capabilities in the Boston biotech hub. The new site in Marlborough also will provide the capacity to support partners in the development and manufacture of COVID-19 vaccines and therapeutics.


Follow Sartorius on Twitter @Sartorius_Group and on LinkedIn.

October 29, 2020
Sartorius to open new Customer Interaction Center in North America
PDF57.3 KB
Back to List

Disclaimer

Sartorius AG published this content on 29 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 November 2020 15:18:01 UTC


© Publicnow 2020
All news about SARTORIUS AG
08:52aSARTORIUS : Partners With RoosterBio to Advance Cell and Gene Therapy Manufactur..
PU
01/06SARTORIUS : to acquire Novasep's chromatography process equipment...
PU
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -2-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -2-
DJ
01/04SARTORIUS VORZUEGE : Receives a Buy rating from JP Morgan
MD
01/04SARTORIUS STEDIM BIOTECH SA : Declaration relative to the number of shares and v..
DJ
2020SARTORIUS : and Evotec Partner With Start-up Curexsys on IPSC-Based...
PU
2020PRESS RELEASE : Evotec and sartorius partner with -2-
DJ
2020SARTORIUS : pays employees a coronavirus bonus
PU
More news
Financials
Sales 2020 2 305 M 2 794 M 2 794 M
Net income 2020 233 M 283 M 283 M
Net Debt 2020 1 759 M 2 132 M 2 132 M
P/E ratio 2020 115x
Yield 2020 0,23%
Capitalization 24 592 M 29 870 M 29 808 M
EV / Sales 2020 11,4x
EV / Sales 2021 9,59x
Nbr of Employees 10 008
Free-Float 46,8%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 246,58 €
Last Close Price 347,00 €
Spread / Highest target 1,15%
Spread / Average Target -28,9%
Spread / Lowest Target -80,2%
EPS Revisions
Managers and Directors
NameTitle
Joachim Kreuzburg Chief Executive Officer
Lothar Kappich Chairman-Supervisory Board
Volker Niebel Head-Production, Procurement & Business Operations
Rainer Lehmann Chief Financial Officer
Oscar-Werner Reif Head-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS AG0.58%29 870
REVENIO GROUP OYJ0.40%1 627
ALPHATEC HOLDINGS, INC.0.76%1 147
CELLAVISION AB (PUBL)2.41%902
VAREX IMAGING CORPORATION12.65%736
OXFORD IMMUNOTEC GLOBAL PLC25.68%570